73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

September 18, 2023Kristi RosaThe European Medicines Agency has granted Priority Medicines designation to iopofosine I-131 for use in patients with Waldenström macroglobulinemia in patients who previou

EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

September 18, 2023Kristi RosaThe European Medicines Agency has granted Priority Medicines designation to iopofosine I-131 for use in patients with Waldenström macroglobulinemia in patients who previou
Who Gets Laryngeal (Voice Box) Cancer?

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al

Who Gets Laryngeal (Voice Box) Cancer?

Dysplasia means precancerous, which isn’t cancer yet, but it could progressByAnna GiorgiPublished on July 24, 2023Medically reviewed byBenjamin F. Asher, MDLaryngeal cancer, al
What to Know About Blood Typing

What to Know About Blood Typing

What to Know About Blood TypingByNancy LeBrunPublished on July 14, 2023Medically reviewed bySteffini Stalos, DOYourblood typeis categorized by certain substances on

What to Know About Blood Typing

What to Know About Blood TypingByNancy LeBrunPublished on July 14, 2023Medically reviewed bySteffini Stalos, DOYourblood typeis categorized by certain substances on
SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

Damian McNamara, MAVANCOUVER, Canada — Use of sodium glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancers among patients withtype 2 diabe

SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

Damian McNamara, MAVANCOUVER, Canada — Use of sodium glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancers among patients withtype 2 diabe
Skin cancer: More people die from types that aren't melanoma, says surprise new finding

Skin cancer: More people die from types that aren't melanoma, says surprise new finding

by Sarah Allinson,The ConversationCredit: AI-generated imageIf you mention skin cancer, most people think of melanoma—the deadliest skin cancer. The other ones are pretty benign, right?Not so. W

Skin cancer: More people die from types that aren't melanoma, says surprise new finding

by Sarah Allinson,The ConversationCredit: AI-generated imageIf you mention skin cancer, most people think of melanoma—the deadliest skin cancer. The other ones are pretty benign, right?Not so. W
New potential therapeutic approach for HER2-positive breast cancer discovered

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co
Gene linked to glioblastoma stem cell self-renewal and immunosuppression

Gene linked to glioblastoma stem cell self-renewal and immunosuppression

by Olivia Dimmer,Northwestern UniversityWorking model. a, Illustration shows a proposed mechanism for the TFPI2 and its associated signaling axis in regulating self-renewal of glioma stem cells

Gene linked to glioblastoma stem cell self-renewal and immunosuppression

by Olivia Dimmer,Northwestern UniversityWorking model. a, Illustration shows a proposed mechanism for the TFPI2 and its associated signaling axis in regulating self-renewal of glioma stem cells
Silent cancers: Here's what you need to know when there are no obvious symptoms

Silent cancers: Here's what you need to know when there are no obvious symptoms

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainThe recent revelations about the Princess of Wales'scancer diagnosishighlight a crucial aspect of cancer detec

Silent cancers: Here's what you need to know when there are no obvious symptoms

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainThe recent revelations about the Princess of Wales'scancer diagnosishighlight a crucial aspect of cancer detec
Rheumatoid Arthritis: Blood Tests for Diagnosis

Rheumatoid Arthritis: Blood Tests for Diagnosis

Rheumatoid Arthritis: Blood Tests for DiagnosisByLana BandoimUpdated on August 07, 2023Medically reviewed byDavid Ozeri, MDRheumatoid arthritis(RA) can be difficult to di

Rheumatoid Arthritis: Blood Tests for Diagnosis

Rheumatoid Arthritis: Blood Tests for DiagnosisByLana BandoimUpdated on August 07, 2023Medically reviewed byDavid Ozeri, MDRheumatoid arthritis(RA) can be difficult to di
New study disentangles a long-standing link between inflammation and cancer progression

New study disentangles a long-standing link between inflammation and cancer progression

byUniversity of OxfordCredit: AI-generated imageA new study published inNature Geneticsled by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unk

New study disentangles a long-standing link between inflammation and cancer progression

byUniversity of OxfordCredit: AI-generated imageA new study published inNature Geneticsled by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unk